LINC02476 Promotes the Malignant Phenotype of Hepatocellular Carcinoma by Sponging MiR-497 and Increasing HMGA2 Expression

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2020 Apr 14

PMID 32280244

Citations 6

Authors

Yuxia Duan

Mengjing Zhao

Mengmeng Jiang

Zhi Li

Caifang Ni

Affiliations

Soon will be listed here.

Abstract

Background: Long noncoding RNAs (lncRNAs) can promote hepatocellular carcinoma (HCC) initiation and progression. In this report, we examined the role of lncRNA LINC02476 in HCC.

Methods: The expression levels of different lncRNAs in HCC were explored using the TCGA database and lncRNA LINC02476 was selected for further study. The expression of LINC02476 in HCC tissues was determined by real-time PCR. The clinicopathological characteristics of HCC patients were analyzed relative to the expression of LINC02476. The expression of LINC02476 was downregulated in HCC cells using a lentiviral vector and different assays were performed to study cell growth, proliferation, invasion, apoptosis and the cell cycle. MiR-497 was selected as a miRNA that could interact with LINC02476 which was further tested by RNA immunoprecipitation. HMGA2 was selected as a possible target of miR-497, and their interaction was examined by a luciferase reporter assay.

Results: LINC02476 expression was elevated in HCC cell lines and HCC tissues. When LINC02476 was downregulated, the growth and the invasion of HCC cells decreased in vitro and in vivo. LINC02476 negatively regulated the expression of miR-497 by acting as a ceRNA. HMGA2 was directly targeted and inhibited by miR-497.

Conclusion: The results indicate that LINC02476 functions through the miR-497/HMGA2 axis and that it has a role in the growth and metastasis of HCC cells. Therefore, LINC02476 could be an interesting new molecular target in HCC therapies.

Citing Articles

Prediction model of clinical prognosis and immunotherapy efficacy of gastric cancer based on level of expression of cuproptosis-related genes.

Zhao B, Wu W, Liang L, Cai X, Chen Y, Tang W Heliyon. 2023; 9(8):e19035.

PMID: 37636385 PMC: 10448029. DOI: 10.1016/j.heliyon.2023.e19035.

High-throughput single nucleus total RNA sequencing of formalin-fixed paraffin-embedded tissues by snRandom-seq.

Xu Z, Zhang T, Chen H, Zhu Y, Lv Y, Zhang S Nat Commun. 2023; 14(1):2734.

PMID: 37173341 PMC: 10182092. DOI: 10.1038/s41467-023-38409-5.

Hyaluronan-mediated motility receptor antisense RNA 1 promotes hepatitis B virus-related hepatocellular carcinoma progression by regulating miR-627-3p/High Mobility Group AT-hook 2 axis.

Zhuang H, Ma X, Liu X, Li C, Li X, Wu L Bioengineered. 2022; 13(4):8617-8630.

PMID: 35322735 PMC: 9162001. DOI: 10.1080/21655979.2022.2054151.

Expression and Diagnostic Value of miR-497 and miR-1246 in Hepatocellular Carcinoma.

Chen S, Fu Z, Wen S, Yang X, Yu C, Zhou W Front Genet. 2021; 12:666306.

PMID: 34163524 PMC: 8215616. DOI: 10.3389/fgene.2021.666306.

miR-497 inhibits proliferation and invasion in triple-negative breast cancer cells via YAP1.

Li Y, Hua K, Jin J, Fang L Oncol Lett. 2021; 22(2):580.

PMID: 34122631 PMC: 8190776. DOI: 10.3892/ol.2021.12841.

References

Cheetham S, Gruhl F, Mattick J, Dinger M . Long noncoding RNAs and the genetics of cancer. Br J Cancer. 2013; 108(12):2419-25. PMC: 3694235. DOI: 10.1038/bjc.2013.233. View

Tu J, Zhao Z, Xu M, Lu X, Chang L, Ji J . NEAT1 upregulates TGF-β1 to induce hepatocellular carcinoma progression by sponging hsa-mir-139-5p. J Cell Physiol. 2018; 233(11):8578-8587. DOI: 10.1002/jcp.26524. View

Weng J, Xiao J, Mi Y, Fang X, Sun Y, Li S . PCDHGA9 acts as a tumor suppressor to induce tumor cell apoptosis and autophagy and inhibit the EMT process in human gastric cancer. Cell Death Dis. 2018; 9(2):27. PMC: 5833845. DOI: 10.1038/s41419-017-0189-y. View

Huang J, Cao S, Ou Q, Yang B, Zheng S, Tang J . The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma. Mol Cancer. 2018; 17(1):93. PMC: 5970477. DOI: 10.1186/s12943-018-0841-x. View

Feng T, Xu D, Tu C, Li W, Ning Y, Ding J . MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4. Tumour Biol. 2015; 36(8):5987-97. DOI: 10.1007/s13277-015-3275-8. View

Ding Q, He K, Luo T, Deng Y, Wang H, Liu H . SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497. Mol Ther. 2016; 24(5):903-14. PMC: 4881782. DOI: 10.1038/mt.2016.9. View

Chen D, Ju H, Lu Y, Chen L, Zeng Z, Zhang D . Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression. J Exp Clin Cancer Res. 2016; 35(1):142. PMC: 5020507. DOI: 10.1186/s13046-016-0420-1. View

Grigoriev A, Bonini N . Age-dependent patterns of microRNA RISC loading. Aging (Albany NY). 2014; 6(9):705-6. PMC: 4221922. DOI: 10.18632/aging.100692. View

Lv J, Kong Y, Gao Z, Liu Y, Zhu P, Yu Z . LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma. Int J Biochem Cell Biol. 2018; 101:19-28. DOI: 10.1016/j.biocel.2018.05.010. View

10.

Zhang W, Zhao Y, Shi Z, Gu G, Cong D, Wei C . HOXA11-AS promotes the migration and invasion of hepatocellular carcinoma cells by inhibiting miR-124 expression by binding to EZH2. Hum Cell. 2019; 32(4):504-514. DOI: 10.1007/s13577-019-00269-x. View

11.

Sun J, Zheng G, Gu Z, Guo Z . MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2. J Neurooncol. 2015; 122(3):481-9. DOI: 10.1007/s11060-015-1753-x. View

12.

Huang J, Zhang S, Gao Y, Liu Y, Liu Y, Zhao Z . MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. Cell Prolif. 2014; 47(4):277-86. PMC: 6496620. DOI: 10.1111/cpr.12109. View

13.

Yuan J, Yang F, Wang F, Ma J, Guo Y, Tao Q . A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014; 25(5):666-81. DOI: 10.1016/j.ccr.2014.03.010. View

14.

Xu G, Li Z, Huang Z, Brunicardi F, Jia F, Song C . MiR-497-5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin-like growth factor 1. Mol Genet Genomic Med. 2019; 7(10):e00860. PMC: 6785451. DOI: 10.1002/mgg3.860. View

15.

Tay H, Plank M, Collison A, Mattes J, Kumar R, Foster P . MicroRNA: potential biomarkers and therapeutic targets for allergic asthma?. Ann Med. 2014; 46(8):633-9. DOI: 10.3109/07853890.2014.958196. View

16.

Zhang Y, Wang Q, Li H, Ye T, Gao F, Liu Y . miR-124 radiosensitizes human esophageal cancer cell TE-1 by targeting CDK4. Genet Mol Res. 2016; 15(2). DOI: 10.4238/gmr.15027893. View

17.

Marquardt J, Thorgeirsson S . SnapShot: Hepatocellular carcinoma. Cancer Cell. 2014; 25(4):550.e1. DOI: 10.1016/j.ccr.2014.04.002. View

18.

Liu Q, Guo X, Que S, Yang X, Fan H, Liu M . LncRNA RSU1P2 contributes to tumorigenesis by acting as a ceRNA against let-7a in cervical cancer cells. Oncotarget. 2016; 8(27):43768-43781. PMC: 5546439. DOI: 10.18632/oncotarget.10844. View

19.

Ma M, Chu B, Zhang Y, Weng M, Qin Y, Gong W . Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis. 2015; 6:e1583. PMC: 4669740. DOI: 10.1038/cddis.2014.541. View

20.

Xiao Y, Jiao C, Lin Y, Chen M, Zhang J, Wang J . lncRNA UCA1 Contributes to Imatinib Resistance by Acting as a ceRNA Against miR-16 in Chronic Myeloid Leukemia Cells. DNA Cell Biol. 2016; 36(1):18-25. DOI: 10.1089/dna.2016.3533. View